This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
BIRNBAUM, YOCHAI
| Item Type | Name |
|
Academic Article
|
Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
|
|
Academic Article
|
Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
|
|
Academic Article
|
Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production.
|
|
Academic Article
|
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
|
|
Academic Article
|
Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
|
|
Academic Article
|
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
|
|
Academic Article
|
Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
|
|
Academic Article
|
The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
|
|
Academic Article
|
Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
|
|
Academic Article
|
The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes.
|
|
Academic Article
|
Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-?-independent manner.
|
|
Concept
|
Thiazolidinediones
|